Risk of hip fracture in patients with a history of schizophrenia

British Journal of Psychiatry

Volumn 190, Issue FEB., 2007, Pages 129-134

  Howard, Louise ^a   Kirkwood, Graham ^a   Leese, Morven ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; ANTICONVULSIVE AGENT; CARBAMAZEPINE; CHLORPROMAZINE; CITALOPRAM; CORTICOSTEROID DERIVATIVE; DROPERIDOL; FLUOXETINE; FLUPENTIXOL; FLUPHENAZINE; FLUVOXAMINE; HALOPERIDOL; HYPNOTIC AGENT; LAXATIVE; NEUROLEPTIC AGENT; OPIATE DERIVATIVE; PAROXETINE; PHENYTOIN; PIMOZIDE; PIPOTIAZINE; PROMAZINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; SULPIRIDE; THIORIDAZINE; TRICYCLIC ANTIDEPRESSANT AGENT; TRIFLUOPERAZINE; UNINDEXED DRUG; ZUCLOPENTHIXOL; ZUCLOPENTHIXOL ACETATE;

AGED; ANAMNESIS; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; DATA BASE; DISEASE ASSOCIATION; DRUG EXPOSURE; FEMALE; GENERAL PRACTICE; HIGH RISK PATIENT; HIP FRACTURE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PROLACTIN BLOOD LEVEL; RISK ASSESSMENT; SCHIZOPHRENIA; SEX DIFFERENCE; SIDE EFFECT; UNIVARIATE ANALYSIS;

ACCIDENTAL FALLS; ANTIPSYCHOTIC AGENTS; BONE DENSITY; CASE-CONTROL STUDIES; FEMALE; HIP FRACTURES; HUMANS; MALE; PROLACTIN; RISK FACTORS; SCHIZOPHRENIA;

EID: 33846947984     PISSN: 00071250     EISSN: None     Source Type: Journal    
DOI: 10.1192/bjp.bp.106.023671     Document Type: Article

References (27)

1. Abraham, G., Halbreich, U., Friedman, R. H., et al (2003) Bone mineral density and prolactin associations in patients with chronic schizophrenia. Schizophrenia Research, 59, 17-18.
2. Bilici, M., Cakirbay, H., Guler, M., et al (2002) Classical and atypical neuroleptics, and bone mineral density, in patients with schizophrenia. International Journal of Neuroscience, 112, 817-828.
3. Bishop, J. R., Alexander, B., Lund, B. C., et al (2004) Osteoporosis screening and treatment in women with schizophrenia: a controlled study. Pharmacotherapy, 24, 515-521.
4. Cumming, R. G., Nevitt, M. C. & Cummings, S. R. (1997) Epidemiology of hip fractures. Epidemiologic Review, 19: 244-257.
5. Cummings, S. R., Browner, W. S., Bauer, D., et al (1998) Endogenous hormones and the risk of hip and vertebral fractures among older women. New England Journal of Medicine, 339, 733-738.
6. Farahmand, B. Y., Michaelsson, K., Baron, J., et al (2000) Body size and hip fracture risk. Epidemiology, 11, 214-219.
7. Hafner, H., an der Heiden, H. W., Behrens, S., et al (1998) Causes and consequences of the gender difference in age at onset of schizophrenia. Schizophrenia Bulletin, 24, 99-113.
8. Halbreich, U. & Palter, S. (1996) Accelerated osteoporosis in psychiatric patients: possible pathophysiological processes. Schizophrenia bulletin, 22, 447-454.
9. Halbreich, U., Rojansky, N., Palter, S., et al (1995) Decreased bone mineral density in medicated psychiatric patients. Psychosomatic Mediane, 57, 485-491.
10. Howard, L. M., Kumar, C., Leese, M., et al (2002) The general fertility rate in women with psychotic disorders. American Journal of Psychiatry, 159, 991-997.
11. Hummer, M. & Huber, J. (2004) Hyperprolactinaernia and antipsychotic therapy in schizophrenia. Current Medical Research Opinion, 20, 189-197.
12. Hummer, M., Malik, P., Gasser, R. W., et al (2005) Osteoporosis in patients with schizophrenia. American Journal of Psychiatry, 142, 162-167.
13. Jenkins, R., Lewis, G., Bebbington, P., et al (1997) The National Psychiatric Morbidity surveys of Great Britain - initial findings from the household survey. Psychological Medicine, 27, 775-789.
14. Kinjo, M., Setoguchi, S., Schneeweiss, S., et al (2005) Bone mineral density in subjects using central nervous system-active medications. American Journal of Medicine, 118, 1414.
15. Koran, L. M., Sox, H. C., Marton, K. I., et al (1989) Medical evaluation of psychiatric patients. I. Results in a state mental health system. Archives of General Psychiatry, 46, 733-740.
16. Koranyi, E. K. (1979) Morbidity and rate of undiagnosed physical illnesses in a psychiatric clinic population. Archives of General Psychiatry, 36, 414-419.
17. Liu-Seifert, H., Kinon, B. J., Ahl, J., et al (2004) Osteopenia associated with increased prolactin and aging in psychiatric patients treated with prolactin-elevating antipsychotics. Annals of the New York Academy of Sciences, 1032, 297-298.
18. Meaney, A. M., Smith, S., Howes, O. D., et al (2004) Effects of long-term prolactin-raising antipsychotic medication on bone mineral density in patients with schizophrenia. British Journal of Psychiatry, 184, 503-508.
19. Misra, M., Papakostas, G. I. & Klibanski, A. (2004) Effects of psychiatric disorders and psychotropic medications on prolactin and bone metabolism. Journal of Clinical Psychiatry, 65, 1607-1618.
20. Naidoo, U., Goff, D. C. & Klibanski, A. (2003) Hyperprolactinemia and bone mineral density: the potential impact of antipsychotic agents. Psychoneuroendocrinology, 28 (suppl. 2), 97-108.
21. Nazareth, I., King, M., Haines, A., et al (1992) Accuracy of diagnosis of psychosis on general practice computer system. BMJ, 307, 32-34.
22. O'Keane, V. & Meaney, A. M. (2005) Antipsychotic drugs: a new risk factor for osteoporosis in young women with schizophrenia? Journal of Clinical Psychopharmacology, 25, 26-31.
23. Redelmeier, D. A., Tan, S. H. & Booth, G. L. (1998) The treatment of unrelated disorders in patients with chronic medical diseases. New England Journal of Medicine, 338, 1516-1520.
24. van Staa, T. P., Leufkens, H. G. & Cooper, C. (2001) Use of inhaled corticosteroids and risk of fractures. Journal of Bone Mineral Research, 16, 581-588.
25. Walley, T. & Mantgani, A. (1997) The UK General Practice Research Database. Lancet, 350, 1097-1099.
26. World Health Organization (1978) International Statistical Classification of Diseases and Related Health Problems (ICD-9). WHO.
27. Yuan, Z., Dawson, N., Cooper, G. S., et al (2001) Effects of alcohol-related disease on hip fracture and mortality: retrospective cohort study of hospitalized Medicare beneficiaries. American Journal of Public Health 91, 1089-1093.